tiprankstipranks
Bausch + Lomb Corporation (BLCO)
NYSE:BLCO
US Market
BLCO
Bausch + Lomb Corporation
RESEARCH TOOLSreports

Bausch + Lomb Corporation (BLCO) Stock News & Sentiment

151 Followers
Bausch + Lomb Wins FDA Clearance for Next-Generation Vitrectomy Cutter and Fluidics Upgrade
Premium
Company Announcements
Bausch + Lomb Wins FDA Clearance for Next-Generation Vitrectomy Cutter and Fluidics Upgrade
21h ago
BLCO
Bausch + Lomb Rolls Out enVista Envy Premium Intraocular Lens Across Europe
Premium
Company Announcements
Bausch + Lomb Rolls Out enVista Envy Premium Intraocular Lens Across Europe
2d ago
BLCO
Bausch + Lomb to Unveil Broad New Ophthalmic Data at ASCRS Meeting
Premium
Company Announcements
Bausch + Lomb to Unveil Broad New Ophthalmic Data at ASCRS Meeting
3d ago
BLCO
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
Premium
Company Announcements
Bausch + Lomb Sets Date for First-Quarter 2026 Results and Investor Call
10d ago
BLCO
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
Premium
Company Announcements
Bausch + Lomb’s ELIOS Glaucoma System Hits Key Efficacy Marks in 24‑Month U.S. Trial
17d ago
BLCO
Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline
Premium
Company Announcements
Bausch + Lomb Launches R&D Webinar Series Spotlighting Glaucoma Pipeline
1M ago
BLCO
Bausch + Lomb Leverages New Global Review to Spotlight LUMIFY’s Edge in Rising Ocular Redness Market
Premium
Company Announcements
Bausch + Lomb Leverages New Global Review to Spotlight LUMIFY’s Edge in Rising Ocular Redness Market
1M ago
BLCO
More BLCO News >

BLCO News on the Web

Bausch + Lomb Wins FDA Clearance for Next-Generation Vitrectomy Cutter and Fluidics Upgrade
TipRanks News
Neutral
Bausch + Lomb receives FDA 510k clearance for Bi-Blade+
TipRanks News
Bullish
Bausch + Lomb Rolls Out enVista Envy Premium Intraocular Lens Across Europe
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Bausch + Lomb Corporation (BLCO) and UnitedHealth (UNH)
TipRanks News
Neutral
Bausch + Lomb announces European availability of enVista Envy lenses
TipRanks News
Neutral
Citi Reaffirms Their Buy Rating on Bausch + Lomb Corporation (BLCO)
TipRanks News
Bullish
Bausch + Lomb to Unveil Broad New Ophthalmic Data at ASCRS Meeting
TipRanks News
Neutral
Bausch + Lomb price target lowered to $17 from $17.50 at Evercore ISI
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
BLCO
Sector Average
Media Buzz
This Week8 articles
Weekly Average3.75 articles
News Sentiment
This Week67%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BLCO’s Media Buzz Sentiment?
8 articles about BLCO were published this week. In an average week, 3.75 articles are published.
    What is BLCO’s weekly average amount of articles?
    In an average week, 3.75 articles about BLCO are published.
      What is BLCO’s News Sentiment?
      67% of articles about BLCO were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        AORTArtivion
        HUMHumana
        ORGOOrganogenesis Holdings
        UNHUnitedHealth Group Incorporated Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S
        Showing the stocks with the most bullish news sentiment over the past week